Barrett's esophagus is a change in the cells lining the lower esophagus, thought to develop as a response to long-term acid exposure, and it's one of the more significant potential complications of chronic, poorly controlled GERD.
What actually changes
The normal squamous cells lining the esophagus are replaced by a different type of cell more similar to intestinal lining tissue. This change itself doesn't cause symptoms beyond whatever reflux symptoms were already present — it's identified through endoscopy with biopsy, not through any distinct symptom of its own.
Why it matters
Barrett's esophagus is associated with an increased risk of esophageal adenocarcinoma, a relatively rare but serious cancer. It's important to keep this in perspective: most people with Barrett's esophagus never develop cancer, but the increased relative risk compared to the general population is why monitoring is generally recommended.
What happens after a diagnosis
A typical plan involves periodic endoscopy with biopsies (the exact interval depends on whether any precancerous changes, called dysplasia, are found) to catch any further concerning changes early, alongside continued aggressive management of the underlying reflux to reduce ongoing acid exposure and potentially slow progression.
This isn't personal medical advice. A Barrett's esophagus diagnosis and its monitoring plan should be guided entirely by your gastroenterologist based on your specific findings.
